Business Description
Turk Ilac ve Serum Sanayi
ISIN : TRETRLC00022
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.63 | |||||
Debt-to-Equity | 0.35 | |||||
Debt-to-EBITDA | 1.47 | |||||
Interest Coverage | 1.5 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 4.51 | |||||
Beneish M-Score | -2.8 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 112.5 | |||||
3-Year EBITDA Growth Rate | 47.8 | |||||
3-Year EPS without NRI Growth Rate | 48.3 | |||||
3-Year FCF Growth Rate | 131.9 | |||||
3-Year Book Growth Rate | 102.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 18.84 | |||||
9-Day RSI | 28.28 | |||||
14-Day RSI | 34.05 | |||||
6-1 Month Momentum % | 111 | |||||
12-1 Month Momentum % | 66.36 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.26 | |||||
Quick Ratio | 1.2 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 15.38 | |||||
Days Sales Outstanding | 116.59 | |||||
Days Payable | 39.72 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 0.4 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 22.43 | |||||
Operating Margin % | 13.58 | |||||
Net Margin % | 6.16 | |||||
FCF Margin % | 10.55 | |||||
ROE % | 13.74 | |||||
ROA % | 7.51 | |||||
ROIC % | 28.71 | |||||
3-Year ROIIC % | 20.76 | |||||
ROC (Joel Greenblatt) % | 22.59 | |||||
ROCE % | 27.01 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 30.86 | |||||
PE Ratio without NRI | 30.58 | |||||
Price-to-Owner-Earnings | 20.55 | |||||
PEG Ratio | 0.69 | |||||
PS Ratio | 1.79 | |||||
PB Ratio | 2.65 | |||||
Price-to-Tangible-Book | 2.57 | |||||
Price-to-Free-Cash-Flow | 15.65 | |||||
Price-to-Operating-Cash-Flow | 11.34 | |||||
EV-to-EBIT | 13.99 | |||||
EV-to-EBITDA | 12.4 | |||||
EV-to-Revenue | 1.87 | |||||
EV-to-FCF | 18.2 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.17 | |||||
Price-to-Graham-Number | 1.84 | |||||
Price-to-Net-Current-Asset-Value | 24.66 | |||||
Earnings Yield (Greenblatt) % | 7.16 | |||||
FCF Yield % | 6.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Turk Ilac ve Serum Sanayi Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₺) | 1,913.261 | ||
EPS (TTM) (₺) | 0.652 | ||
Beta | 0 | ||
Volatility % | 70.44 | ||
14-Day RSI | 34.05 | ||
14-Day ATR (₺) | 1.383211 | ||
20-Day SMA (₺) | 22.09 | ||
12-1 Month Momentum % | 66.36 | ||
52-Week Range (₺) | 10.98 - 39.18 | ||
Shares Outstanding (Mil) | 161.81 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Turk Ilac ve Serum Sanayi Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Turk Ilac ve Serum Sanayi Stock Events
Event | Date | Price(₺) | ||
---|---|---|---|---|
No Event Data |
Turk Ilac ve Serum Sanayi Frequently Asked Questions
What is Turk Ilac ve Serum Sanayi(IST:TRILC)'s stock price today?
When is next earnings date of Turk Ilac ve Serum Sanayi(IST:TRILC)?
Does Turk Ilac ve Serum Sanayi(IST:TRILC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |